| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.4 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.12 | 0.4 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |